Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN/LKB1-deficient mice

BACKGROUND: The PI3K–mTOR (phosphoinositide 3-kinase–mammalian target of rapamycin kinase) pathway is activated in the majority of tumours, and there is interest in assessing whether inhibitors of PI3K or mTOR kinase have efficacy in treating cancer. Here, we define the effectiveness of specific mTO...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: García-Martínez, J M, Wullschleger, S, Preston, G, Guichard, S, Fleming, S, Alessi, D R, Duce, S L
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2011
Konular:
Translational Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068512/
https://ncbi.nlm.nih.gov/pubmed/21407213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.83
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller